Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 42, 2023 - Issue 2
640
Views
0
CrossRef citations to date
0
Altmetric
Original Investigation

Outcome of eviscerations and enucleations at a Swedish tertiary referral centre between 2008 and 2019: improved surgical management leading to reduced complication rate

ORCID Icon
Pages 174-180 | Received 07 Feb 2022, Accepted 12 May 2022, Published online: 25 May 2022

References

  • Beard CH. Enucleation. In: Ophthalmic Surgery. Philadelphia, USA: Blakiston’s Son & Co; 1910:457–477.
  • Mules PH. Evisceration of the eye and its relation to the bacterial theory of the origin of sympathetic disease. Trans Ophthalmol Soc UK. 1885;5200.
  • Kim JM, Sung JY, Lim HB, Choi EJ, Lee SB. Risk factors for orbital implant extrusion after evisceration. J Clin Med. 2021;10(15). doi:10.3390/jmc10153329.
  • Habib LA, North VS, Freitag SK, Yoon MK, Lefebvre DR, Grace Lee N. Medical comorbidities and orbital implant exposure. Acta Ophthalmol. 2021;100(3):e813–e819. doi:10.1111/aos.14973.
  • Gauthier AC, Oduyale OK, Fliotsos MJ, et al. Clinical characteristics and outcomes in patients undergoing primary or secondary enucleation or evisceration after ocular trauma. Clin Ophthalmol. 2020;14:3499–3506. doi:10.2147/OPTH.S273760.
  • Al-Farsi HA, Sabt BI, Al-Mujaini AS. Orbital implant exposure following enucleation or evisceration. Oman J Ophthalmol. 2017;10(2):87–90. doi:10.4103/ojo.OJO_156_2016.
  • Chiu SJ, Tan JHY, Currie ZI. To implant or not to implant: emergency orbital eviscerations with primary orbital implants. Eye (Lond). 2021;35(11):3077–3086. doi:10.1038/s41433-020-01382-0.
  • Sobti MM, Shams F, Jawaheer L, Cauchi P, Chadha V. Unwrapped hydroxyapatite orbital implants: our experience in 347 cases. Eye (Lond). 2020;34(4):675–682. doi:10.1038/s41433-019-0571-3.
  • Bohman E. Att återskapa ett öga: nio års erfarenhet av enukleationer, eviscerationer och sekundära implantationer vid ögonkliniken SU/Mölndal. Skövde: Västra Götalandsregionen; 2009.
  • Masdottir S, Sahlin S. Patient satisfaction and results after evisceration with a split-sclera technique. Orbit. 2007;26(4):241–247. doi:10.1080/01676830600985916.
  • Nakra T, Simon GJ, Douglas RS, Schwarcz RM, McCann JD, Goldberg RA. Comparing outcomes of enucleation and evisceration. Ophthalmology. 2006;113(12):2270–2275. doi:10.1016/j.ophtha.2006.06.021.
  • Yousuf SJ, Jones LS, Kidwell ED Jr. Enucleation and evisceration: 20 years of experience. Orbit. 2012;31(4):211–215. doi:10.3109/01676830.2011.639477.
  • Roelofs KA, Aghazadeh H, Cheema M, Weis E, Badilla J. Enucleation and evisceration: an analysis of indications, histopathological findings, and surgical trends over 23 years at a tertiary care hospital in western Canada. Can J Ophthalmol. 2019;54(1):106–110. doi:10.1016/j.jcjo.2018.02.026.
  • Lin CW, Liao SL. Long-Term complications of different porous orbital implants: a 21-year review. Br J Ophthalmol. 2017;101(5):681–685. doi:10.1136/bjophthalmol-2016-308932.
  • Ranno S, Serafino M, Nucci P. Four petal evisceration versus standard technique: a retrospective study. Eur J Ophthalmol. 2021;31(4):2156–2159. doi:10.1177/1120672120950160.
  • Kord Valeshabad A, Naseripour M, Asghari R, et al. Enucleation and evisceration: indications, complications and clinicopathological correlations. Int J Ophthalmol. 2014;7(4):677–680. doi:10.3980/j.issn.2222-3959.2014.04.17.
  • Alwitry A, West S, King J, Foss AJ, Abercrombie LC. Long-Term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthalmic Plast Reconstr Surg. 2007;23(1):11–15. doi:10.1097/01.iop.0000249429.02757.6b.
  • Gupta R, Hari P, Khurana B, Kiran A. Risk factors for orbital implant exposure after evisceration: a case control study of 93 patients. Indian J Ophthalmol. 2019;67(7):1148–1151. doi:10.4103/ijo.IJO_1813_18.